I think you've hit the nail on the head, if we consider the C19 ARDS trial as a Phase 2B, then we are in a good chance with a properly informed trial design for Phase 3 for C19 ARDS...
There's plenty to look forward to.
Glad to have you back posting again mate & in a better mood too
The market response has been underwhelming, but this was never a one day event - I'm just glad that we've finally stopped the bleeding and that the re-rate cycle has started
Stay strong
Ann: COVID ARDS Trial Topline 60-Day Results, page-158
-
- There are more pages in this discussion • 1,471 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |